China National Medicines Corporation Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 3,024

Employees

  • Stock Symbol
  • 600511

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $4.27
  • (As of Friday Closing)

China National Medicines Corporation General Information

Description

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.

Contact Information

Website
www.cncm.com.cn
Formerly Known As
Sinopharm Pharmaceutical Company
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Floors 6-9, West Tower, 7th Floor
  • Number 8 Courtyard, Yongdingmen West Binhe Road, Dongcheng District
  • Beijing, 100077
  • China
+86 010
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Floors 6-9, West Tower, 7th Floor
  • Number 8 Courtyard, Yongdingmen West Binhe Road, Dongcheng District
  • Beijing, 100077
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

China National Medicines Corporation Stock Performance

As of 20-Nov-2026, China National Medicines Corporation’s stock price is $4.27. Its current market cap is $3.23B with 755M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.27 $4.33 $3.69 - $4.48 $3.23B 755M 4.66M $0.38

China National Medicines Corporation Financials Summary

As of 30-Sep-2026, China National Medicines Corporation has a trailing 12-month revenue of $7.79B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,065,929 2,358,961 2,744,304 2,235,016
Revenue 7,789,905 7,296,057 7,051,457 7,024,295
EBITDA 371,281 390,671 393,149 423,447
Net Income 287,342 277,639 278,745 303,327
Total Assets 5,491,493 5,243,190 4,784,630 4,578,209
Total Debt 75,194 73,788 115,882 77,237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

China National Medicines Corporation Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore China National Medicines Corporation‘s full profile, request access.

Request a free trial

China National Medicines Corporation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

China National Medicines Corporation Acquisitions (1)

China National Medicines Corporation’s most recent deal was a Merger/Acquisition with Sinopharm Holding Beijing Tianxingpuxin Bio-Med Company for . The deal was made on 01-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sinopharm Holding Beijing Tianxingpuxin Bio-Med Company 01-Apr-2017 Merger/Acquisition Holding Companies
To view China National Medicines Corporation’s complete acquisitions history, request access »

China National Medicines Corporation ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

37.53 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view China National Medicines Corporation’s complete esg history, request access »

China National Medicines Corporation FAQs

  • When was China National Medicines Corporation founded?

    China National Medicines Corporation was founded in 1999.

  • Where is China National Medicines Corporation headquartered?

    China National Medicines Corporation is headquartered in Beijing, China.

  • What is the size of China National Medicines Corporation?

    China National Medicines Corporation has 3,024 total employees.

  • What industry is China National Medicines Corporation in?

    China National Medicines Corporation’s primary industry is Pharmaceuticals.

  • Is China National Medicines Corporation a private or public company?

    China National Medicines Corporation is a Public company.

  • What is China National Medicines Corporation’s stock symbol?

    The ticker symbol for China National Medicines Corporation is 600511.

  • What is the current stock price of China National Medicines Corporation?

    As of 20-Nov-2026 the stock price of China National Medicines Corporation is $4.27.

  • What is the current market cap of China National Medicines Corporation?

    The current market capitalization of China National Medicines Corporation is $3.23B.

  • What is China National Medicines Corporation’s current revenue?

    The trailing twelve month revenue for China National Medicines Corporation is $7.79B.

  • What is China National Medicines Corporation’s annual earnings per share (EPS)?

    China National Medicines Corporation’s EPS for 12 months was $0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process